the objectives of this open , prospective , randomized and comparative study were to evaluate and compare the efficacy and safety of intravenous ceftriaxone ( active ingredient of rocephin ) and cefotaxime in treatment of bacterial pneumoniae .
C0007561
ceftriaxone
C0004626
bacterial